Heron Therapeutics
HRTX
#7833
Rank
S$0.32 B
Marketcap
$2.14
Share price
3.27%
Change (1 day)
-9.62%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.60

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.59. In 2022 the company made an earnings per share (EPS) of -$2.35 an increase over its 2021 EPS that were of -$3.05.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.60-31.62%
2022-$2.35-23.11%
2021-$3.05-10%
2020-$3.39-0%
2019-$3.391.21%
2018-$3.35-32.7%
2017-$4.98-19.34%
2016-$6.1754.76%
2015-$3.991.73%
2014-$3.92-16.23%
2013-$4.6891.67%
2012-$2.44-31.45%
2011-$3.56-27.06%
2010-$4.88-43.75%
2009-$8.68-57.33%
2008-$20.35-82.92%
2007-$119.1220.61%
2006-$98.77175.76%
2005-$35.82-21.43%
2004-$45.59100%
2003-$22.79-38.24%
2002-$36.90161.54%
2001-$14.11-106.46%
2000$218.292051.55%
1999$10.15839.73%
1998$1.08-105.48%
1997-$19.72-88.16%
1996-$166.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.76-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.19-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.21 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.13-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.24 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA